Pharmaceuticals

Global Dengue Vaccines Market Insights, Forecast to 2025

  • QYR2788836
  • 113 Pages
  • October 2018
  • Pharmaceuticals
Download Sample    Get Discount   
 
In 2017, the global Dengue Vaccines market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Dengue Vaccines market based on company, product type, application and key regions.

This report studies the global market size of Dengue Vaccines in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Dengue Vaccines in these regions.

This research report categorizes the global Dengue Vaccines market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

The various contributors involved in the value chain of Dengue Vaccines include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Dengue Vaccines include

Sanofi

Takeda Pharmaceutical

Market Size Split by Type

CYD-TDV

Tak-003

Other

Market Size Split by Application

Hospitals

Government Institutes

Non-Governmental Organizations (NGOs)

Market size split by Region

North America

United States

Canada

Mexico

Asia-Pacific

China

India

Japan

South Korea

Australia

Indonesia

Singapore

Malaysia

Philippines

Thailand

Vietnam

Europe

Germany

France

UK

Italy

Spain

Russia

Central & South America

Brazil

Rest of Central & South America

Middle East & Africa

GCC Countries

Turkey

Egypt

South Africa

The study objectives of this report are:

To study and analyze the global Dengue Vaccines market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.

To understand the structure of Dengue Vaccines market by identifying its various subsegments.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

Focuses on the key global Dengue Vaccines manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Dengue Vaccines with respect to individual growth trends, future prospects, and their contribution to the total market.

To project the value and volume of Dengue Vaccines submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Dengue Vaccines are as follows:

History Year: 2013-2017

Base Year: 2017

Estimated Year: 2018

Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Dengue Vaccines market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Study Coverage

1.1 Dengue Vaccines Product

1.2 Key Market Segments

1.3 Key Manufacturers Covered

1.4 Market by Type

1.4.1 Global Dengue Vaccines Market Size Growth Rate by Type

1.4.2 CYD-TDV

1.4.3 Tak-003

1.4.4 Other

1.5 Market by Application

1.5.1 Global Dengue Vaccines Market Size Growth Rate by Application

1.5.2 Hospitals

1.5.3 Government Institutes

1.5.4 Non-Governmental Organizations (NGOs)

1.6 Study Objectives

1.7 Years Considered

2 Executive Summary

2.1 Global Dengue Vaccines Market Size

2.1.1 Global Dengue Vaccines Revenue 2016-2025

2.1.2 Global Dengue Vaccines Sales 2016-2025

2.2 Dengue Vaccines Growth Rate by Regions

2.2.1 Global Dengue Vaccines Sales by Regions

2.2.2 Global Dengue Vaccines Revenue by Regions

3 Breakdown Data by Manufacturers

3.1 Dengue Vaccines Sales by Manufacturers

3.1.1 Dengue Vaccines Sales by Manufacturers

3.1.2 Dengue Vaccines Sales Market Share by Manufacturers

3.1.3 Global Dengue Vaccines Market Concentration Ratio (CR5 and HHI)

3.2 Dengue Vaccines Revenue by Manufacturers

3.2.1 Dengue Vaccines Revenue by Manufacturers (2016-2018)

3.2.2 Dengue Vaccines Revenue Share by Manufacturers (2016-2018)

3.3 Dengue Vaccines Price by Manufacturers

3.4 Dengue Vaccines Manufacturing Base Distribution, Product Types

3.4.1 Dengue Vaccines Manufacturers Manufacturing Base Distribution, Headquarters

3.4.2 Manufacturers Dengue Vaccines Product Category

3.4.3 Date of International Manufacturers Enter into Dengue Vaccines Market

3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type

4.1 Global Dengue Vaccines Sales by Type

4.2 Global Dengue Vaccines Revenue by Type

4.3 Dengue Vaccines Price by Type

5 Breakdown Data by Application

5.1 Overview

5.2 Global Dengue Vaccines Breakdown Data by Application

6 North America

6.1 North America Dengue Vaccines by Countries

6.1.1 North America Dengue Vaccines Sales by Countries

6.1.2 North America Dengue Vaccines Revenue by Countries

6.1.3 United States

6.1.4 Canada

6.1.5 Mexico

6.2 North America Dengue Vaccines by Type

6.3 North America Dengue Vaccines by Application

6.4 North America Dengue Vaccines by Company

7 Europe

7.1 Europe Dengue Vaccines by Countries

7.1.1 Europe Dengue Vaccines Sales by Countries

7.1.2 Europe Dengue Vaccines Revenue by Countries

7.1.3 Germany

7.1.4 France

7.1.5 UK

7.1.6 Italy

7.1.7 Russia

7.2 Europe Dengue Vaccines by Type

7.3 Europe Dengue Vaccines by Application

7.4 Europe Dengue Vaccines by Company

8 Asia Pacific

8.1 Asia Pacific Dengue Vaccines by Countries

8.1.1 Asia Pacific Dengue Vaccines Sales by Countries

8.1.2 Asia Pacific Dengue Vaccines Revenue by Countries

8.1.3 China

8.1.4 Japan

8.1.5 Korea

8.1.6 India

8.1.7 Australia

8.1.8 Indonesia

8.1.9 Malaysia

8.1.10 Philippines

8.1.11 Thailand

8.1.12 Vietnam

8.1.13 Singapore

8.2 Asia Pacific Dengue Vaccines by Type

8.3 Asia Pacific Dengue Vaccines by Application

8.4 Asia Pacific Dengue Vaccines by Company

9 Central & South America

9.1 Central & South America Dengue Vaccines by Countries

9.1.1 Central & South America Dengue Vaccines Sales by Countries

9.1.2 Central & South America Dengue Vaccines Revenue by Countries

9.1.3 Brazil

9.2 Central & South America Dengue Vaccines by Type

9.3 Central & South America Dengue Vaccines by Application

9.4 Central & South America Dengue Vaccines by Company

10 Middle East and Africa

10.1 Middle East and Africa Dengue Vaccines by Countries

10.1.1 Middle East and Africa Dengue Vaccines Sales by Countries

10.1.2 Middle East and Africa Dengue Vaccines Revenue by Countries

10.1.3 GCC Countries

10.1.4 Turkey

10.1.5 Egypt

10.1.6 South Africa

10.2 Middle East and Africa Dengue Vaccines by Type

10.3 Middle East and Africa Dengue Vaccines by Application

10.4 Middle East and Africa Dengue Vaccines by Company

11 Company Profiles

11.1 Sanofi

11.1.1 Sanofi Company Details

11.1.2 Company Description

11.1.3 Sales, Revenue and Gross Margin of Dengue Vaccines

11.1.4 Dengue Vaccines Product Description

11.1.5 Recent Development

11.2 Takeda Pharmaceutical

11.2.1 Takeda Pharmaceutical Company Details

11.2.2 Company Description

11.2.3 Sales, Revenue and Gross Margin of Dengue Vaccines

11.2.4 Dengue Vaccines Product Description

11.2.5 Recent Development

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis

12.1 Market Opportunities and Drivers

12.2 Market Challenges

12.3 Market Risks/Restraints

12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis

13.1 Value Chain Analysis

13.1.1 Typical Suppliers of Key Dengue Vaccines Raw Material

13.1.2 Dengue Vaccines Customers

13.2 Sales Channels Analysis

13.2.1 Sales Channels Analysis

13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

15.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Author Details

15.3 Disclaimer

List of Tables and Figures

Figure Picture of Dengue Vaccines

Figure Global Dengue Vaccines Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)

Figure Global Dengue Vaccines Production Market Share by Types (Product Category) in 2017

Figure CYD-TDV Product Picture

Table Major Manufacturers of CYD-TDV

Figure Tak-003 Product Picture

Table Major Manufacturers of Tak-003

Figure Other Product Picture

Table Major Manufacturers of Other

Table Global Dengue Vaccines Market Size Growth Rate by Application 2018-2025 (K Units)

Figure Hospitals

Figure Government Institutes

Figure Non-Governmental Organizations (NGOs)

Figure Dengue Vaccines Report Years Considered

Figure Global Dengue Vaccines Market Size 2016-2025 (Million US$)

Figure Global Dengue Vaccines Sales 2016-2025 (K Units)

Table Global Dengue Vaccines Market Size by Regions 2016-2025 (K Units) & (Million US$)

Table Global Dengue Vaccines Sales by Regions 2016-2025 (K Units)

Table Global Dengue Vaccines Sales Market Share by Regions 2016-2025

Figure Global Dengue Vaccines Sales Market Share by Regions 2016-2025

Figure 2017 Global Dengue Vaccines Sales Market Share by Regions

Table Global Dengue Vaccines Revenue by Regions 2016-2025 (Million US$)

Table Global Dengue Vaccines Revenue Market Share by Regions 2016-2025

Figure Global Dengue Vaccines Revenue Market Share by Regions 2016-2025

Figure 2017 Global Dengue Vaccines Revenue Market Share by Regions

Table Global Dengue Vaccines Sales by Manufacturers (2016-2018) (K Units)

Table Global Dengue Vaccines Sales Share by Manufacturers (2016-2018)

Figure Global Dengue Vaccines Sales Share by Manufacturers in 2017

Table Dengue Vaccines Revenue by Manufacturers (2016-2018) (Million US$)

Table Dengue Vaccines Revenue Share by Manufacturers (2016-2018)

Figure Dengue Vaccines Value Share by Manufacturers in 2017

Table Global Dengue Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)

Table Key Manufacturers Dengue Vaccines Price (2016-2018) (USD/Unit)

Table Dengue Vaccines Manufacturers Manufacturing Base Distribution and Headquarters

Table Manufacturers Dengue Vaccines Product Category

Table Date of International Manufacturers Enter into Dengue Vaccines Market

Table Manufacturers Mergers & Acquisitions, Expansion Plans

Table Global Dengue Vaccines Sales by Type (2016-2025) (K Units)

Table Global Dengue Vaccines Sales Share by Type (2016-2025)

Figure Global Dengue Vaccines Sales Market Share by Type (2016-2025)

Figure Global Dengue Vaccines Sales Market Share by Type in 2017

Table Global Dengue Vaccines Revenue by Type (2016-2025) (Million US$)

Table Global Dengue Vaccines Revenue Share by Type (2016-2025)

Figure Global Dengue Vaccines Revenue Market Share by Type (2016-2025)

Figure Global Dengue Vaccines Revenue Market Share by Type in 2017

Table Dengue Vaccines Price by Type 2013-2018 (USD/Unit)

Table Global Dengue Vaccines Sales by Application (2016-2025) (K Units)

Table Global Dengue Vaccines Sales Share by Application (2016-2025)

Figure Global Sales Dengue Vaccines Market Share by Application (2016-2025)

Figure Global Sales Dengue Vaccines Market Share by Application (2016-2025)

Figure North America Dengue Vaccines Sales Growth Rate 2016-2025 (K Units)

Figure North America Dengue Vaccines Revenue Growth Rate 2016-2025 (Million US$)

Table North America Dengue Vaccines Sales by Countries (2016-2025) (K Units)

Table North America Dengue Vaccines Sales Market Share by Countries (2016-2025)

Figure 2017 North America Dengue Vaccines Sales Market Share by Countries

Table North America Dengue Vaccines Revenue by Countries (2016-2025) (Million US$)

Table North America Dengue Vaccines Revenue Market Share by Countries (2016-2025)

Figure 2017 North America Dengue Vaccines Revenue Market Share by Countries

Figure United States Dengue Vaccines Sales Growth Rate (2016-2025) (K Units)

Figure United States Dengue Vaccines Revenue Growth Rate (2016-2025) (Million US$)

Figure Canada Dengue Vaccines Sales Growth Rate (2016-2025) (K Units)

Figure Canada Dengue Vaccines Revenue Growth Rate (2016-2025) (Million US$)

Figure Mexico Dengue Vaccines Sales Growth Rate (2016-2025) (K Units)

Figure Mexico Dengue Vaccines Revenue Growth Rate (2016-2025) (Million US$)

Table North America Dengue Vaccines Sales by Type (2016-2025) (K Units)

Table North America Dengue Vaccines Sales Market Share by Type (2016-2025)

Figure 2017 North America Dengue Vaccines Market Share by Type

Table North America Dengue Vaccines Sales by Application (2016-2025) (K Units)

Table North America Dengue Vaccines Sales Market Share by Application (2016-2025)

Figure 2017 North America Dengue Vaccines Market Share by Application

Table North America Dengue Vaccines Sales by Company (2016-2018) (K Units)

Table North America Dengue Vaccines Sales Market Share by Company (2016-2018)

Figure North America Dengue Vaccines Sales Market Share by Company in 2017

Figure Europe Dengue Vaccines Sales Growth Rate 2016-2025 (K Units)

Figure Europe Dengue Vaccines Revenue Growth Rate 2016-2025 (Million US$)

Table Europe Dengue Vaccines Sales by Countries (2016-2025) (K Units)

Table Europe Dengue Vaccines Sales Market Share by Countries (2016-2025)

Figure 2017 Europe Dengue Vaccines Sales Market Share by Countries

Table Europe Dengue Vaccines Revenue by Countries (2016-2025) (Million US$)

Table Europe Dengue Vaccines Revenue Market Share by Countries (2016-2025)

Figure 2017 Europe Dengue Vaccines Revenue Market Share by Countries

Figure Germany Dengue Vaccines Sales Growth Rate (2016-2025) (K Units)

Figure Germany Dengue Vaccines Revenue Growth Rate (2016-2025) (K Units)

Figure France Dengue Vaccines Sales Growth Rate (2016-2025) (K Units)

Figure France Dengue Vaccines Revenue Growth Rate (2016-2025) (K Units)

Figure UK Dengue Vaccines Sales Growth Rate (2016-2025) (K Units)

Figure UK Dengue Vaccines Revenue Growth Rate (2016-2025) (Million US$)

Figure Italy Dengue Vaccines Sales Growth Rate (2016-2025) (K Units)

Figure Italy Dengue Vaccines Revenue Growth Rate (2016-2025) (Million US$)

Figure Russia Dengue Vaccines Sales Growth Rate (2016-2025) (K Units)

Figure Russia Dengue Vaccines Revenue Growth Rate (2016-2025) (Million US$)

Table Europe Dengue Vaccines Sales by Type (2016-2025) (K Units)

Table Europe Dengue Vaccines Sales Market Share by Type (2016-2025)

Figure 2017 Europe Dengue Vaccines Market Share by Type

Table Europe Dengue Vaccines Sales by Application (2016-2025) (K Units)

Table Europe Dengue Vaccines Sales Market Share by Application (2016-2025)

Figure 2017 Europe Dengue Vaccines Market Share by Application

Table Europe Dengue Vaccines Sales by Company (2016-2018) (K Units)

Table Europe Dengue Vaccines Sales Market Share by Company (2016-2018)

Figure Europe Dengue Vaccines Sales Market Share by Company in 2017

Figure Asia Pacific Dengue Vaccines Sales Growth Rate 2016-2025 (K Units)

Figure Asia Pacific Dengue Vaccines Revenue Growth Rate 2016-2025 (Million US$)

Table Asia Pacific Dengue Vaccines Sales by Countries (2016-2025) (K Units)

Table Asia Pacific Dengue Vaccines Sales Market Share by Countries (2016-2025)

Figure 2017 Asia Pacific Dengue Vaccines Sales Market Share by Countries

Table Asia Pacific Dengue Vaccines Revenue by Countries (2016-2025) (Million US$)

Table Asia Pacific Dengue Vaccines Revenue Market Share by Countries (2016-2025)

Figure 2017 Asia Pacific Dengue Vaccines Revenue Market Share by Countries

Figure China Dengue Vaccines Sales Growth Rate (2016-2025) (K Units)

Figure China Dengue Vaccines Revenue Growth Rate (2016-2025) (Million US$)

Figure Japan Dengue Vaccines Sales Growth Rate (2016-2025) (K Units)

Figure Japan Dengue Vaccines Revenue Growth Rate (2016-2025) (Million US$)

Figure Korea Dengue Vaccines Sales Growth Rate (2016-2025) (K Units)

Figure Korea Dengue Vaccines Revenue Growth Rate (2016-2025) (Million US$)

Figure India Dengue Vaccines Sales Growth Rate (2016-2025) (K Units)

Figure India Dengue Vaccines Revenue Growth Rate (2016-2025) (Million US$)

Figure Australia Dengue Vaccines Sales Growth Rate (2016-2025) (K Units)

Figure Australia Dengue Vaccines Revenue Growth Rate (2016-2025) (Million US$)

Figure Indonesia Dengue Vaccines Sales Growth Rate (2016-2025) (K Units)

Figure Indonesia Dengue Vaccines Revenue Growth Rate (2016-2025) (Million US$)

Figure Malaysia Dengue Vaccines Sales Growth Rate (2016-2025) (K Units)

Figure Malaysia Dengue Vaccines Revenue Growth Rate (2016-2025) (Million US$)

Figure Philippines Dengue Vaccines Sales Growth Rate (2016-2025) (K Units)

Figure Philippines Dengue Vaccines Revenue Growth Rate (2016-2025) (Million US$)

Figure Thailand Dengue Vaccines Sales Growth Rate (2016-2025) (K Units)

Figure Thailand Dengue Vaccines Revenue Growth Rate (2016-2025) (Million US$)

Figure Vietnam Dengue Vaccines Sales Growth Rate (2016-2025) (K Units)

Figure Vietnam Dengue Vaccines Revenue Growth Rate (2016-2025) (Million US$)

Figure Singapore Dengue Vaccines Sales Growth Rate (2016-2025) (K Units)

Figure Singapore Dengue Vaccines Revenue Growth Rate (2016-2025) (Million US$)

Table Asia Pacific Dengue Vaccines Sales by Type (2016-2025) (K Units)

Table Asia Pacific Dengue Vaccines Sales Market Share by Type (2016-2025)

Figure 2017 Asia Pacific Dengue Vaccines Market Share by Type

Table Asia Pacific Dengue Vaccines Sales by Application (2016-2025) (K Units)

Table Asia Pacific Dengue Vaccines Sales Market Share by Application (2016-2025)

Figure 2017 Asia Pacific Dengue Vaccines Market Share by Application

Table Asia Pacific Dengue Vaccines Sales by Company (2016-2018) (K Units)

Table Asia Pacific Dengue Vaccines Sales Market Share by Company (2016-2018)

Figure Asia Pacific Dengue Vaccines Sales Market Share by Company in 2017

Figure Central & South America Dengue Vaccines Sales Growth Rate 2016-2025 (K Units)

Figure Central & South America Dengue Vaccines Revenue Growth Rate 2016-2025 (Million US$)

Table Central & South America Dengue Vaccines Sales by Countries (2016-2025) (K Units)

Table Central & South America Dengue Vaccines Sales Market Share by Countries (2016-2025)

Figure 2017 Central & South America Dengue Vaccines Sales Market Share by Countries

Table Central & South America Dengue Vaccines Revenue by Countries (2016-2025) (Million US$)

Table Central & South America Dengue Vaccines Revenue Market Share by Countries (2016-2025)

Figure 2017 Central & South America Dengue Vaccines Revenue Market Share by Countries

Figure Brazil Dengue Vaccines Sales Growth Rate (2016-2025) (K Units)

Figure Brazil Dengue Vaccines Revenue Growth Rate (2016-2025) (Million US$)

Figure Argentina Dengue Vaccines Sales Growth Rate (2016-2025) (K Units)

Figure Argentina Dengue Vaccines Revenue Growth Rate (2016-2025) (Million US$)

Table Central & South America Dengue Vaccines Sales by Type (2016-2025) (K Units)

Table Central & South America Dengue Vaccines Sales Market Share by Type (2016-2025)

Figure 2017 Central & South America Dengue Vaccines Market Share by Type

Table Central & South America Dengue Vaccines Sales by Application (2016-2025) (K Units)

Table Central & South America Dengue Vaccines Sales Market Share by Application (2016-2025)

Figure 2017 Central & South America Dengue Vaccines Market Share by Application

Table Central & South America Dengue Vaccines Sales by Company (2016-2018) (K Units)

Table Central & South America Dengue Vaccines Sales Market Share by Company (2016-2018)

Figure Central & South America Dengue Vaccines Sales Market Share by Company in 2017

Figure Middle East and Africa Dengue Vaccines Sales Growth Rate 2016-2025 (K Units)

Figure Middle East and Africa Dengue Vaccines Revenue Growth Rate 2016-2025 (Million US$)

Table Middle East and Africa Dengue Vaccines Sales by Countries (2016-2025) (K Units)

Table Middle East and Africa Dengue Vaccines Sales Market Share by Countries (2016-2025)

Figure 2017 Middle East and Africa Dengue Vaccines Sales Market Share by Countries

Table Middle East and Africa Dengue Vaccines Revenue by Countries (2016-2025) (Million US$)

Table Middle East and Africa Dengue Vaccines Revenue Market Share by Countries (2016-2025)

Figure 2017 Middle East and Africa Dengue Vaccines Revenue Market Share by Countries

Figure GCC Countries Dengue Vaccines Sales Growth Rate (2016-2025) (K Units)

Figure GCC Countries Dengue Vaccines Revenue Growth Rate (2016-2025) (Million US$)

Figure Turkey Dengue Vaccines Sales Growth Rate (2016-2025) (K Units)

Figure Turkey Dengue Vaccines Revenue Growth Rate (2016-2025) (Million US$)

Figure Egypt Dengue Vaccines Sales Growth Rate (2016-2025) (K Units)

Figure Egypt Dengue Vaccines Revenue Growth Rate (2016-2025) (Million US$)

Figure South Africa Dengue Vaccines Sales Growth Rate (2016-2025) (K Units)

Figure South Africa Dengue Vaccines Revenue Growth Rate (2016-2025) (Million US$)

Table Middle East and Africa Dengue Vaccines Sales by Type (2016-2025) (K Units)

Table Middle East and Africa Dengue Vaccines Sales Market Share by Type (2016-2025)

Figure 2017 Middle East and Africa Dengue Vaccines Market Share by Type

Table Middle East and Africa Dengue Vaccines Sales by Application (2016-2025) (K Units)

Table Middle East and Africa Dengue Vaccines Sales Market Share by Application (2016-2025)

Figure 2017 Middle East and Africa Dengue Vaccines Market Share by Application

Table Middle East and Africa Dengue Vaccines Sales by Company (2016-2018) (K Units)

Table Middle East and Africa Dengue Vaccines Sales Market Share by Company (2016-2018)

Figure Middle East and Africa Dengue Vaccines Sales Market Share by Company in 2017

Table Sanofi Company Details

Table Sanofi Dengue Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)

Table Sanofi Recent Development

Table Takeda Pharmaceutical Company Details

Table Takeda Pharmaceutical Dengue Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)

Table Takeda Pharmaceutical Recent Development

Figure GDP by Regions / Largest Economies Pie Chart in 2016

Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060

Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016

Figure Saving Rate Total, % of GDP, 2015

Table Dengue Vaccines Value Chain

Table Typical Suppliers of Key Dengue Vaccines Raw Material

Table Dengue Vaccines Customers List

Table Dengue Vaccines Sales Channels

Table Dengue Vaccines Distributors List

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370